Finance

ื’ืจืกืช ื‘ื˜ื
ืจืฉื™ืžื•ืช
ืžื’ื–ืจื™ ืžื ื™ื•ืช
ืกืžืœื™ื
ืกืžืœื™ื
ืžื—ื™ืจ
ืฉื™ื ื•ื™
ืื—ื•ื– ื”ืฉื™ื ื•ื™
ืžื’ืžื”
ืฉืขืจ ื”ื ืขื™ืœื” ื”ืงื•ื“ื
ืคืชื™ื—ื”
ื’ื‘ื•ื”
ื ืžื•ืš
ื ืคื—
ืฉื•ื•ื™ ืฉื•ืง
SIXB
Materials
SIXB
Materials
SIXB
+0.05%โ€
1,104.60
+0.50โ€
+0.05%โ€
โ€”1,101.371,103.921,108.191,103.92โ€”โ€”
SIXC
Communications
SIXC
Communications
SIXC
+0.11%โ€
604.82
+0.66โ€
+0.11%โ€
โ€”604.16604.16606.67604.12โ€”โ€”
SIXE
Energy
SIXE
Energy
SIXE
+1.19%โ€
1,212.10
+14.29โ€
+1.19%โ€
โ€”1,198.831,200.581,213.071,200.58โ€”โ€”
SIXI
Industrials
SIXI
Industrials
SIXI
+0.25%โ€
1,744.80
+4.39โ€
+0.25%โ€
โ€”1,755.951,739.551,748.011,739.55โ€”โ€”
SIXM
Financials
SIXM
Financials
SIXM
+0.36%โ€
636.74
+2.30โ€
+0.36%โ€
โ€”638.51633.13638.41633.01โ€”โ€”
SIXR
Staples
SIXR
Staples
SIXR
โ€Ž-0.40%โ€
837.52
โ€Ž-3.38โ€
โ€Ž-0.40%โ€
โ€”843.52839.53840.52838.70โ€”โ€”
SIXRE
Real estate
SIXRE
Real estate
SIXRE
โ€Ž-0.03%โ€
215.07
โ€Ž-0.060โ€
โ€Ž-0.03%โ€
โ€”215.13215.13215.74214.56โ€”โ€”
SIXT
Technology
SIXT
Technology
SIXT
โ€Ž-0.12%โ€
3,224.92
โ€Ž-3.79โ€
โ€Ž-0.12%โ€
โ€”3,138.913,225.623,227.743,215.52โ€”โ€”
SIXU
Utilities
SIXU
Utilities
SIXU
+0.43%โ€
939.93
+4.06โ€
+0.43%โ€
โ€”934.37938.37941.92938.37โ€”โ€”
SIXV
Health care
SIXV
Health care
SIXV
+0.15%โ€
1,459.36
+2.24โ€
+0.15%โ€
โ€”1,477.431,452.741,461.111,449.55โ€”โ€”
SIXY
Discretionary
SIXY
Discretionary
SIXY
โ€Ž-0.58%โ€
2,385.98
โ€Ž-13.86โ€
โ€Ž-0.58%โ€
โ€”2,380.192,389.712,391.992,384.62โ€”โ€”
S2P:FRA
Simcere Pharmaceutical Group Ltd
โ€1.32ย โ€โ‚ฌ
+0.76%โ€
(+0.010โ€) ื™ื•ื
27 ื‘ืืคืจืณ, 08:07:54 GMTโ€Ž+2โ€Ž  ·   EUR
ื›ืœ ื”ืกืžืœื™ื
ืกืžืœืžื—ื™ืจืฉื™ื ื•ื™ืื—ื•ื– ื”ืฉื™ื ื•ื™
ื”ืžืขืจื›ืช ื™ื•ืฆืจืช ืจืฉื™ืžืช ืชื•ื‘ื ื•ืช ืขื™ืงืจื™ื•ืช ืœื’ื‘ื™ S2Pโ€ฆ
ืคืชื™ื—ื”
โ€1.32ย โ€โ‚ฌ
ื’ื‘ื•ื”
โ€1.32ย โ€โ‚ฌ
ื ืžื•ืš
โ€1.32ย โ€โ‚ฌ
ืฉื•ื•ื™ ื”ืฉื•ืง
31.80Bโ€
ื ืคื— ืžืžื•ืฆืข
400.00
ื ืคื—
0.00
ืฉื™ื ืฉืœ 52 ืฉื‘ื•ืขื•ืช
โ€1.60ย โ€โ‚ฌ
ืฉืคืœ ืฉืœ 52 ืฉื‘ื•ืขื•ืช
โ€0.94ย โ€โ‚ฌ
ืžืกืคืจ ื”ืขื•ื‘ื“ื™ื
7Kโ€
ื—ื“ืฉื•ืช
ืžืžืงื•ืจื•ืช ืฉื•ื ื™ื ืžืจื—ื‘ื™ ื”ืื™ื ื˜ืจื ื˜
TipRanks
TipRanks
·
ืœืคื ื™ 11 ื“ืงื•ืช
EUDA Health Warned by Nasdaq Over Market Value, Given Until October to Regain Compliance
CNBC
CNBC
·
ืœืคื ื™ 17 ื“ืงื•ืช
Opening Bell: April 27, 2026
Investing.com
Investing.com
·
ืœืคื ื™ 19 ื“ืงื•ืช
Jaguar Health receives Nasdaq extension, plans 1-for-35 reverse split
MarketBeat
MarketBeat
·
ืœืคื ื™ 20 ื“ืงื•ืช
Lakeland Financial (NASDAQ:LKFN) Issues Quarterly Earnings Results, Beats Estimates By $0.03 EPS
ืคืจื•ืคื™ืœ
Simcere Pharmaceutical Group or Simcere Pharmaceutical is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market. Its focus is to introduce generic and pharmaceutical products for the treatment of diseases with high incidence and/or mortality rate. The company has introduced a generic anti-stroke medication under the brand name, Bicun, and an anti-cancer medication under the brand name, Endu. Its products include antibiotics, anti-stroke medications, anti-inflammatory drugs, anti-cancer medications and other medicines. In addition, it has obtained approvals from the China State Food and Drug Administration to manufacture and sell over 210 other products. Wikipedia
ืžื™ื“ืข ืขืœ Simcere Pharmaceutical Group Ltd
ืžื ื›"ืœ/ื™ืชRen Jinsheng
ืžืกืคืจ ื”ืขื•ื‘ื“ื™ื7.04Kโ€
ืชืืจื™ืš ื”ื”ืงืžื”1995
ื”ืžืฉืจื“ื™ื ื”ืจืืฉื™ื™ืื ืื ื’'ื™ื ื’, ื’'ื™ืื ื’ืกื•, ืกื™ืŸ
ืžื’ื–ืจ-
ืืชืจsimcere.com
ื”ื“ื•ื—ื•ืช ื”ืงื•ื“ืžื™ืื›ืœ ื”ืขืจื›ื™ื ื ืงื•ื‘ื™ื ื‘ืžื˜ื‘ืข USD
Loading Previous Earnings...
ื“ื•ื— ืจื•ื•ื— ื•ื”ืคืกื“
ื”ื›ื ืกื•ืช
ืจื•ื•ื— ื ืงื™
ื›ืœ ื”ืขืจื›ื™ื ื ืงื•ื‘ื™ื ื‘ืžื˜ื‘ืข CNY
ืžืจืฅ 2025
ื™ื•ื ื™ 2025
ืกืคื˜ืณ 2025
ื“ืฆืžืณ 2025
ื”ื›ื ืกื•ืช
1.79Bโ€
1.79Bโ€
2.07Bโ€
2.07Bโ€
ืขืœื•ืช ื”ืžื›ืจ
345.53Mโ€
345.53Mโ€
365.25Mโ€
365.25Mโ€
ืขืœื•ืช ื”ื”ื›ื ืกื•ืช
345.53Mโ€
345.53Mโ€
365.25Mโ€
365.25Mโ€
ื”ื•ืฆืื•ืช ืžื—ืงืจ ื•ืคื™ืชื•ื—
316.21Mโ€
316.21Mโ€
465.30Mโ€
465.30Mโ€
ืกืš ื”ื•ืฆืื•ืช ืžื—ืงืจ ื•ืคื™ืชื•ื—
-
-
-
-
ื”ื•ืฆืื•ืช ืžื›ื™ืจื” ื•ืžื ื”ืœ ื•ื”ื•ืฆืื•ืช ื›ืœืœื™ื•ืช
807.37Mโ€
807.37Mโ€
949.52Mโ€
949.52Mโ€
ื”ื•ืฆืื•ืช ืชืคืขื•ืœ
1.09Bโ€
1.09Bโ€
1.36Bโ€
1.36Bโ€
ืกืš ื”ื•ืฆืื•ืช ืชืคืขื•ืœ
1.44Bโ€
1.44Bโ€
1.72Bโ€
1.72Bโ€
ืจื•ื•ื— ืชืคืขื•ืœื™
357.23Mโ€
357.23Mโ€
351.33Mโ€
351.33Mโ€
ื”ื›ื ืกื•ืช ืœื ืชืคืขื•ืœื™ื•ืช
-
-
-
-
ืจื•ื•ื— ืœืคื ื™ ืžืก ื›ื•ืœืœ ืกืขื™ืคื™ื ื—ืจื™ื’ื™ื
331.24Mโ€
331.24Mโ€
425.92Mโ€
425.92Mโ€
ืจื•ื•ื— ืœืคื ื™ ืžืก ื‘ื ื™ื›ื•ื™ ืกืขื™ืคื™ื ื—ืจื™ื’ื™ื
350.09Mโ€
350.09Mโ€
348.89Mโ€
348.89Mโ€
ื”ื•ืฆืื” ืœืžืก ื”ื›ื ืกื”
29.44Mโ€
29.44Mโ€
55.72Mโ€
55.72Mโ€
ืฉื™ืขื•ืจ ื”ืžืก ื”ืืคืงื˜ื™ื‘ื™
8.89%
8.89%
13.08%
13.08%
ื”ื•ืฆืื•ืช ืชืคืขื•ืœ ืื—ืจื•ืช
โ€Ž-34.30Mโ€
โ€Ž-34.30Mโ€
โ€Ž-56.27Mโ€
โ€Ž-56.27Mโ€
ืจื•ื•ื— ื ืงื™
301.80Mโ€
301.80Mโ€
370.20Mโ€
370.20Mโ€
ืฉื™ืขื•ืจ ื”ืจื•ื•ื— ื”ื ืงื™
16.84%
16.84%
17.86%
17.86%
ืจื•ื•ื— ืœืžื ื™ื”
-
-
-
-
ื”ื›ื ืกื•ืช ืžืจื™ื‘ื™ืช ื•ื”ืฉืงืขื•ืช
13.27Mโ€
13.27Mโ€
14.60Mโ€
14.60Mโ€
ื”ื•ืฆืื•ืช ืจื™ื‘ื™ืช
โ€Ž-24.27Mโ€
โ€Ž-24.27Mโ€
โ€Ž-23.63Mโ€
โ€Ž-23.63Mโ€
ื”ื•ืฆืื•ืช ืจื™ื‘ื™ืช ื ื˜ื•
โ€Ž-10.99Mโ€
โ€Ž-10.99Mโ€
โ€Ž-9.03Mโ€
โ€Ž-9.03Mโ€
ื”ื•ืฆืื•ืช ืคื—ืช ื•ื”ืคื—ืชื•ืช
-
-
-
-
ืจื•ื•ื— ืœืคื ื™ ืจื™ื‘ื™ืช, ืžื™ืกื™ื, ืคื—ืช ื•ื”ืคื—ืชื•ืช (EBITDA)
409.84Mโ€
409.84Mโ€
403.94Mโ€
407.12Mโ€
ืจื•ื•ื— ืื• ื”ืคืกื“ ืžืžื›ื™ืจืช ื ื›ืกื™ื
-
-
-
-
ืชื•ื›ืŸ ืž-AI ืขืœื•ืœ ืœื›ืœื•ืœ ื˜ืขื•ื™ื•ืช. ืžื™ื“ืข ื ื•ืกืฃ
ืขื–ืจื”ืฉืœื™ื—ืช ืžืฉื•ื‘ืคืจื˜ื™ื•ืชืชื ืื™ืื›ืชื‘ ื•ื™ืชื•ืจ

ืžื—ืงืจ

ื”ืžืฉื™ืžื•ืช ืฉืœื™
ืขื“ื™ื™ืŸ ืœื ื™ืฆืจืช ืžืฉื™ืžื”
ื”ืžืฉื™ืžื•ืช ืฉืœืš ื™ื•ืคื™ืขื• ื›ืืŸ. ืืคืฉืจ ืœืชื–ืžืŸ ืžืฉื™ืžื•ืช ื•ืœืชืช ืœ-Google Finance ืœื‘ืฆืข ืื•ืชืŸ ื‘ืœื™ ื”ืชืขืจื‘ื•ืช ืฉืœืš.
ืชื‘ื ื™ื•ืช
ืชืงืฆื™ืจ ืขืœ ื”ืžื ื™ื•ืช ืฉื‘ืžืขืงื‘
ื ื™ืชื•ื— ื™ื•ืžื™ ืฉืœ ื”ืžื ื™ื•ืช ืฉื‘ืžืขืงื‘ ืœืคื ื™ ืคืชื™ื—ืช ื”ืžืกื—ืจ
ืจื•ื•ื—ื™ื ืฆืคื•ื™ื™ื
ื“ื•ื—ื•ืช ืจื•ื•ื—ื™ื ืฉืฆืคื•ื™ื™ื ืœื”ืชืคืจืกื ื”ืฉื‘ื•ืข
ืชื ื•ื“ืชื™ื•ืช ื•ื ืคื— ื—ืจื™ื’ื™ื
ืื–ื”ืจื” ืžื•ืงื“ืžืช ืขืœ ืชื ื•ื“ืชื™ื•ืช ื•ื ืคื— ื”ื™ื•ื
ืชื•ื›ืŸ ืž-AI ืขืœื•ืœ ืœื›ืœื•ืœ ื˜ืขื•ื™ื•ืช. ืžื™ื“ืข ื ื•ืกืฃ
ืขื–ืจื”ืฉืœื™ื—ืช ืžืฉื•ื‘ืคืจื˜ื™ื•ืชืชื ืื™ืื›ืชื‘ ื•ื™ืชื•ืจ